Safety of isotreinoin treatment in peanut and soy allergy

Marco Zurlo; Stefano Palazzo; Nada Chaoul; Marcello Albanesi

doi:10.5114/ada.2023.128981

Abstract

3/2023 vol. 40

Letter to the Editor

Safety of isotreinoin treatment in peanut and soy allergy

Marco Zurlo ^{1, 2}

,

Stefano Palazzo ²

,

Nada Chaoul ^{2, 3}

,

Marcello Albanesi ²

Department of Medicine, Asthma, Allergy and Clinical Immunology Section, University of Verona, Verona, Italy
Marcello Albanesi Allergy and Immunology Unit, Bari, Italy
Department of Interdisciplinary Medicine, Oncology Section, University of Bari, Bari, Italy

Adv Dermatol Allergol 2023; XL (3): 462–463

DOI: https://doi.org/10.5114/ada.2023.128981

Online publish date: 2023/07/16

View full text

AMA

Zurlo M, Palazzo S, Chaoul N, Albanesi M. Safety of isotreinoin treatment in peanut and soy allergy. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(3):462-463. doi:10.5114/ada.2023.128981.

APA

Zurlo, M., Palazzo, S., Chaoul, N., & Albanesi, M. (2023). Safety of isotreinoin treatment in peanut and soy allergy. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(3), 462-463. https://doi.org/10.5114/ada.2023.128981

Chicago

Zurlo, Marco, Stefano Palazzo, Nada Chaoul, and Marcello Albanesi. 2023. "Safety of isotreinoin treatment in peanut and soy allergy". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 40 (3): 462-463. doi:10.5114/ada.2023.128981.

Harvard

Zurlo, M., Palazzo, S., Chaoul, N., and Albanesi, M. (2023). Safety of isotreinoin treatment in peanut and soy allergy. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(3), pp.462-463. https://doi.org/10.5114/ada.2023.128981

MLA

Zurlo, Marco et al. "Safety of isotreinoin treatment in peanut and soy allergy." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 40, no. 3, 2023, pp. 462-463. doi:10.5114/ada.2023.128981.

Vancouver

Zurlo M, Palazzo S, Chaoul N, Albanesi M. Safety of isotreinoin treatment in peanut and soy allergy. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(3):462-463. doi:10.5114/ada.2023.128981.

Share

Indexed in

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications